24/7 Market News – (NASDAQ: IINN) INSPIRA TECHNOLOGIES shares are surging up this morning more than 60% as traders digest this morning’s news.
Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (ART), designed to rebalance patient oxygen saturation levels. The Company’s ART™ technology potentially allows patients to remain awake during treatment while minimizing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company’s product has not yet been tested or used in humans and has not been approved by any regulatory entity.
For more information, please visit our corporate website:
https://inspira-technologies.com/
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the potential design and function of the HYLA™ blood sensor, the potential benefits that may be realized through the use of the HYLA™ blood sensor, that the HYLA™ blood sensor is being designed to target the “Point of Care” testing, ABG (Arterial Blood Gas) analyzer market, and the potential size of that market, and that Inspira™ Technologies has set out to change the way patient health is monitored. These forward-looking statements and their implications are based solely on the current expectations of the Company’s management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website, www.sec.gov
For more details:
US Investor Relations
Miri Segal,
MS-IR LLC
+917-607-8654
US Public Relations
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
IINN@redchip.com
MRK-ARS-026
Copyright © 2018-2022 Inspira Technologies OXY B.H.N. LTD., All rights reserved.
Photo: https://mma.prnewswire.com/media/1853436/HYLA_Blood_Sensor.jpg
Logo: https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg
SOURCE Inspira Technologies